Search Cancer Clinical Trials

Mass General Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
10 results
  • Sarcoma, Thyroid Cancer, Breast Cancer, Head and Neck Cancer, Pancreatic Cancer, Liver Cancer, Lung Cancer, Ovarian Cancer, Kidney Cancer

23-301          Phase I

A First-in-Human, Open-label, Multicenter, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX-201 in Participants with Advanced Solid Tumors

  • Sarcoma, Ovarian Cancer, Gastric (Stomach) Cancer

24-169          Phase I

A Molecularly Driven Phase 1b Dose Escalation and Dose Expansion Study of the DNA-PK Inhibitor Peposertib (M3814) in Combination with the ATR Inhibitor M1774

  • Sarcoma, Pancreatic Cancer, Liver Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Endometrial Cancer, Bladder Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation

  • Prostate Cancer, Pancreatic Cancer, Lung Cancer, Kidney Cancer, Gastric (Stomach) Cancer, Sarcoma, Colorectal Cancer, Cervical Cancer, Bladder Cancer, Endometrial Cancer, Breast Cancer

23-392          Phase I

A Phase 1a/1b, Dose-Escalation/Dose-Expansion study of NPX267 in Subjects with Solid Tumors Known to Express HHLA-2

  • Sarcoma

21-437          Phase II

A Phase 1b/2 Trial of Lurbinectedin plus Doxorubicin in Leiomyosarcoma

  • Sarcoma

16-626          Phase I

A Phase I Trial of CBT-1® in Combination with Doxorubicin in Patients with Locally Advanced or Metastatic, Unresectable Sarcomas Previously to Have Progressed on 150 mg/m2 or less of Doxorubicin

  • Sarcoma

21-492          Phase II

A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma

  • Breast Cancer, Gastric (Stomach) Cancer, Lung Cancer, Sarcoma, Esophageal Cancer

22-361          Phase I

Phase 1, first-in-human, open-label dose escalation and cohort expansion study of KB-0742 in patients with relapsed or refractory solid tumors or non-Hodgkin lymphoma

  • Breast Cancer, Sarcoma, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Gastric (Stomach) Cancer, Colorectal Cancer

21-304          Phase I

Phase I, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM14 Administered Intravenously to Patients with Advanced Solid Tumors

  • Sarcoma

21-547          Phase III

SARC041: Phase 3 Randomized Double-Blind Study of Abemaciclib versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

Showing 1 - 10 of 10 results